Table 3 Effect of CurNPs and ZnONPs administration on serum lipid profile TC, TG, HDL-c and LDL levels of STZ-induced diabetic and control rats.
Groups | TC (mg/dl) | HDL-c (mg/dl) | TG (mg/dl) | LDL-c (mg/dl) |
|---|---|---|---|---|
Control | 80.6 ± 0.68e | 59.80 ± 0.58a | 92.60 ± 0.93 h | 2.28 ± 0.67f. |
HFD/STZ | 532.80 ± 1.66a | 24.80 ± 0.66d | 391.00 ± 0.71a | 229.80 ± 1.16a |
HFD/STZ-Cur | 161.00 ± 0.71b | 41.00 ± 0.71b,c | 201.00 ± 0.71c | 79.80 ± 0.91b |
HFD/STZ-CurNPs-10 | 70.00 ± 0.71f. | 40.00 ± 0.71c | 122.00 ± 0.71f. | 5.60 ± 0.49e |
HFD/STZ-CurNPs-50 | 74.80 ± 0.86f. | 41.40 ± 0.93b,c | 131.00 ± 0.71e | 7.20 ± 0.42d |
HFD/STZ- ZnSO4 | 109.20 ± 2.35c | 43.60 ± 1.03b | 217.80 ± 0.86b | 22.04 ± 2.54c |
HFD/STZ-ZnONPs-10 | 90.60 ± 0.93d | 42.00 ± 0.71b | 110.00 ± 0.71 g | 26.60 ± 0.76c |
HFD/STZ-ZnONPs-50 | 70.00 ± 0.71f. | 42.60 ± 0.93b | 119.80 ± 0.86 g | 3.44 ± 1.09f. |
HFD/STZ-MT | 83.00 ± 0.71e | 45.00 ± 0.71b | 144.00 ± 0.71d | 9.20 ± 0.97d |